For people receiving urate-lowering therapy, NICE recommends aiming for a serum urate below 360 micromol/L (6 mg/dL). A lower target below 300 micromol/L (5 mg/dL) may be considered in some people, including those with tophi, chronic gouty arthritis or continuing frequent flares.
For people receiving urate-lowering therapy, NICE recommends aiming for a serum urate below 360 micromol/L (6 mg/dL). A lower target below 300 micromol/L (5 mg/dL) may be considered in some people, including those with tophi, chronic gouty arthritis or continuing frequent flares.
For people receiving urate-lowering therapy, NICE recommends aiming for a serum urate below 360 micromol/L (6 mg/dL). A lower target below 300 micromol/L (5 mg/dL) may be considered in some people, including those with tophi, chronic gouty arthritis or continuing frequent flares.
This is general educational information, not medical advice.
General educational information, not individual medical advice. Do not start, stop or change prescribed treatment based on this page.